Sildenafil Treatment of Subacute Ischemic Stroke: A Safety Study at 25-mg Daily for 2 Weeks

Journal of Stroke and Cerebrovascular Diseases

Volumn 18, Issue 5, 2009, Pages 381-383

  Silver, Brian ^a   McCarthy, Sharon ^a   Lu, Mei ^a   Mitsias, Panayiotis ^a   Russman, Andrew N ^a   Katramados, Angelos ^a   Morris, Daniel C ^a   Lewandowski, Christopher A ^a   Chopp, Michael ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

safety; sildenafil; Stroke

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BLOOD PRESSURE MONITORING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COLOR VISION DEFECT; COMORBIDITY; DEEP VEIN THROMBOSIS; DISEASE EXACERBATION; DISEASE SURVEILLANCE; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPEPSIA; FEMALE; FLUSHING; FOLLOW UP; HEARING LOSS; HEART INFARCTION; HUMAN; HYPOTENSION; INFORMED CONSENT; LUNG EMBOLISM; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIAPISM; PRIORITY JOURNAL; RANKIN SCALE; SCORING SYSTEM; SIDE EFFECT; STROKE; STROKE PATIENT; SUDDEN DEATH; SUICIDE; SURVIVOR; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG TOXICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PULMONARY EMBOLISM; PURINES; RECOVERY OF FUNCTION; STROKE; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 69149103302     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2009.01.007     Document Type: Article

References (15)

1. Zhang R., Wang Y., Zhang L., et al. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 33 (2002) 2675-2680
2. Zhang R., Wang L., Zhang L., et al. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res 92 (2003) 308-313
3. Zhang L., Zhang R.L., Wang Y., et al. Functional recovery in aged and young rats after embolic stroke: Treatment with a phosphodiesterase type 5 inhibitor. Stroke 36 (2005) 847-852
4. Wang L., Gang Zhang Z., Lan Zhang R., et al. Activation of the PI3-K/Akt pathway mediates cGMP enhanced-neurogenesis in the adult progenitor cells derived from the subventricular zone. J Cereb Blood Flow Metab 25 (2005) 1150-1158
5. Zhang R.L., Zhang Z., Zhang L., et al. Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J Neurosci Res 83 (2006) 1213-1219
6. Li L., Jiang Q., Zhang L., et al. Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. Brain Res 1132 (2007) 185-192
7. Zhang L., Zhang Z., Zhang R.L., et al. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Res 1118 (2006) 192-198
8. Silver B., Grover K.M., Arcila X., et al. Recovery in a patient with locked-in syndrome. Can J Neurol Sci 33 (2006) 246-249
9. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
10. Sherman D.G., Albers G.W., Bladin C., et al. PREVAIL Investigators. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischemic stroke (PREVAIL study): An open-label randomized comparison. Lancet 369 (2007) 1347-1355
11. Viagra (sildenafil citrate) Information. US Food and Drug Administration. Viagra (sildenafil citrate) Information. Available from: http://www.fda.gov/cder/consumerinfo/viagra/default.htm. Accessed April 7, 2008.
12. Paul G.A., Gibbs J.S.R., Boobis A.R., et al. Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension. Br J Clin Pharmacol 60 (2005) 107-112
13. Nichols D.J., Muirhead G.J., and Harness J.A. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: Absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol 53 (2002) 5S-12S (suppl)
14. Muirhead G.J., Rance D.J., Walker D.K., et al. Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil citrate. Br J Clin Pharmacol 53 (2002) 13S-20S (suppl)
15. Edwards G., and Muirhead G. Introduction to the pharmacokinetics and pharmacodynamics of sildenafil citrate. Br J Clin Pharmacol 53 (2002) 1S-3S (suppl)